Publications by authors named "M Tetart"
Objectives: We aimed to assess the frequency, management, and burden of enterococcal-related vascular graft infection.
Patients And Methods: From 2008 to 2021, data regarding all episodes of vascular graft infections initially managed or secondarily referred to our referral center were prospectively collected. We described the history and management of the infection, depending on the type of prosthesis used.
Introduction: Polypharmacy can lead to drug-drug interactions (DDIs), especially with ART. The burden of co-medications, including over-the-counter (OTC) drugs and self-medications, could be underestimated. We aimed to investigate the proportion of people living with HIV (PLHIV) with declared and undeclared co-medications, as well as their potential burden.
View Article and Find Full Text PDFIntroduction: Since 2017, pre-exposure prophylaxis (PrEP) has been one of the tools in combination HIV prevention strategies. The objective of our questionnaire was to analyze the knowledge and the position of general practitioners in Hauts-de-France on PrEP.
Method: This quantitative, observational, cross-sectional study was conducted in 2020 using an anonymous questionnaire sent by post to a sample of 3007 GPs.
Article Synopsis
- Staphylococci are responsible for about 60% of periprosthetic joint infections, and while rifampicin is the usual treatment, it has significant side effects.
- This study compares rifabutin and rifampicin in terms of their effectiveness against staphylococcal strains from these infections, focusing on their minimal inhibitory, bactericidal, and biofilm eradication concentrations.
- Results show that rifabutin is generally more effective than rifampicin against certain Staphylococcus strains, particularly concerning biofilm eradication, highlighting the need for further in vivo studies to confirm these findings.
To assess the prevalence of COVID-19 in people living with HIV (PLWHIV), we performed an epidemiological survey from 1 April through 1 August 2020 in an HIV reference center in Northern France. PLWHIV completed a questionnaire about risk exposures and symptoms consistent with COVID-19 and performed a SARS-CoV-2 serology. Among the 600 PLWHIV included, 16 have been infected with SARS-CoV-2.
View Article and Find Full Text PDF